Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment

Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment

Abstract Background To determine the feasibility, acceptability, and preliminary efficacy of a 6-month tailored non-linear progressive physical activity intervention (PAI) for lymphoma patients undergoing chemotherapy. Methods Patients newly diagnosed with lymphoma (non-Hodgkin (NHL) or Hodgkin (HL)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Juliana V. Costa, Alexander R. Lucas, Shannon L. Mihalko, Peter H. Brubaker, Alexandra Marshall, Brianna Leitzelar, Brianna R. Wolle, Samuel Norton, R. Lee Franco, Jeremy Via, Victor Yazbeck, Rakhee Vaidya, Mary Beth Seegars, Ralph D’Agostino, Lynne Wagner, W. Gregory Hundley
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Pilot and Feasibility Studies
Subjects:	Exercise capacity Physical activity Lymphoma Cardiotoxicity Health-related quality of life Randomized controlled pilot trial
Online Access:	https://doi.org/10.1186/s40814-024-01580-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
by: Monika Długosz‐Danecka, et al.
Published: (2019-03-01)

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
by: Marijke Linschoten, et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Analysis of the cardiotoxic and myorelaxant effects of camphor on fish of the Nile tilapia species (Oreochromis niloticus) (Linnaeus 1758)
by: Clarissa Araújo da Paz, et al.
Published: (2025-01-01)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01)

Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population
by: Wang RH, et al.
Published: (2025-02-01)

Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
by: Hesong Shen, et al.
Published: (2025-01-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Advances in the pilot point inverse method: Où En Sommes-Nous maintenant?
by: White, Jeremy, et al.
Published: (2023-01-01)

Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
by: Sneha Samir Babaria, et al.
Published: (2025-01-01)

Cardiotoxicity of polystyrene nanoplastics and associated mechanism of myocardial cell injury in mice
by: Ziyi Xiong, et al.
Published: (2025-01-01)

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
by: Tytti-Maria Uurasmaa, et al.
Published: (2025-01-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)

Treatment of primary esophageal lymphomas: A review
by: Joe El Khoury, et al.
Published: (2025-02-01)

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Evaluation of miR-146a as a potential biomarker for diagnosis of cardiotoxicity induced by chemotherapy in patients with breast cancer
by: Nasrin Zare, et al.
Published: (2025-01-01)

Scopoletin as a cardioprotective agent against cisplatin-induced oxidative stress and inflammation
by: Esam Qnais, et al.
Published: (2025-02-01)

Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor
by: Yuting Wu, et al.
Published: (2025-02-01)

Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
by: Muluabay Getie, et al.
Published: (2025-01-01)

Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity
by: Shanaz Khodaiji, et al.
Published: (2024-04-01)

Primary Breast Anaplastic Large-Cell Lymphoma
by: Min-Hong Wang, et al.
Published: (2023-10-01)

WIND ENERGY POTENTIAL IN THE EAST OF ROMANIA
by: NICOLAE RUSAN
Published: (2010-07-01)

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

Cardiac Markers in Pediatric Laboratory Medicine: Critical Review
by: Renata Zrinski Topic, et al.
Published: (2025-01-01)

Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity
by: Zhang Q, et al.
Published: (2025-01-01)

A study of the propensity for communicative aggressiveness in cadet pilots
by: M. V. Erkhova, et al.
Published: (2024-05-01)

A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy
by: Jing Yang, et al.
Published: (2025-02-01)

Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
by: Kai Tao, et al.
Published: (2025-02-01)

Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
by: Zhao M, et al.
Published: (2025-01-01)

Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity
by: María de Regla Caballero-Valderrama, et al.
Published: (2024-12-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2024-04-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2023-07-01)

Bilateral breast swelling in a pregnant woman with high-grade B-cell lymphoma, potentially Burkitt lymphoma
by: Chi Bao Tran Nguyen, MD, et al.
Published: (2025-03-01)

Ultrasonographic manifestations of a rare case of gallbladder lymphoma
by: Wei Wang, et al.
Published: (2025-02-01)

Symptoms affecting patient’s intake of food with lymphoma in outpatient chemotherapy
by: Andressa Madalozo Laffitte, et al.
Published: (2015-07-01)

Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
by: Irene Cartas‐Espinel, et al.
Published: (2022-06-01)

Facial Profile of Young Indian Women from Maharashtra-A Cross-Sectional Pilot Study
by: Om N. Baghele, et al.
Published: (2023-07-01)

Oxytocin as a physiological correlate of dyadic music therapy relationships — a randomized crossover pilot study
by: Paula Kristin Busse, et al.
Published: (2025-01-01)